Table 5.
Drug | QTc prolongation | Hypotension | Sedation | Weight gain | Metabolic syndrome | Extrapyramidal symptoms | Anticholinergic | Prolactin elevation |
---|---|---|---|---|---|---|---|---|
Amisulpride | + | − | − | − | + | + | − | +++ |
Aripiprazole | − | − | − | +/− | +/− | +/− | − | − |
Asenapine | + | − | + | − | − | + | − | +/− |
Chlorpromazine | ++ | +++ | +++ | ++ | ++ | ++ | ++ | +++ |
Clozapine | + | +++ | +++ | +++ | +++ | − | +++ | − |
Haloperidol | +++ | + | + | + | + | +++ | + | +++ |
Olanzapine | + | + | ++ | +++ | +++ | +/− | + | + |
Paliperidone | −/+ | ++ | + | ++ | ++ | + | + | +++ |
Quetiapine | ++ | ++ | ++ | ++ | ++ | − | + | − |
Risperidone | + | ++ | + | ++ | ++ | + | + | +++ |
Sulpiride | + | − | − | + | + | + | − | +++ |
Abbreviations: +++, high incidence/severity; ++, moderate incidence/severity; +, low incidence/severity; −, very low incidence/severity. Adapted from The Maudsley Prescribing Guidelines 10th Edition.30